Search results
Handelman is a certified public accountant, and holds a degree in accounting from the City University of New York. Mr. Anthony Cataldo, the Chairman and Chief Executive Officer of GT Biopharma commented "Michael was CFO when I first created what is now known as Iovance Biotherapeutics, Inc. (IOVA).
The Board has appointed Dr. Gregory Berk as interim CEO, and Dr. Gavin Choy as acting CFO. Michael Breen has assumed the role of Executive Chairman of the Board, Chair of the Audit Committee and will oversee the transition. The Board has initiated a search process to identify individuals for permanent positions for both CEO and CFO roles.
Nov 18, 2020 · GT Biopharma Appoints Michael Handelman, CPA as Chief Financial Officer Download as PDF November 18, 2020 BEVERLY HILLS, CA / ACCESSWIRE /... eedda371be22e15c849ede2384dc.m2Lmerqeq6T_WvKNylG_ulgPVcXgzbFC4ooyuCoeeiw.rSGuEPfb-e6vKMP0_AiK9wlMIJ-Uutd7odhnjmtmGGuqBJFPj8-a16sPxg
Michael Handelman. Highest Rated: 48% Night at the Museum: Secret of the Tomb (2014) Lowest Rated: 19% The Ex (2006) Birthday: Not Available ...
Nov 18, 2020 · GT Biopharma, Inc. announced Michael Handelman, CPA has been appointed Chief Financial Officer of the company. Prior to joining the company, Mr. Handelman served as Chief Financial Officer of Iovance...
Nov 18, 2020 · GT Biopharma, Inc. an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager technology is pleased to announce Michael Handelman, CPA has been ...
Dec 6, 2021 · Pursuant to an Officer Agreement between Clickstream Corporation and Michael Handelman (“Executive”), effective December 1, 2021, Executive was appointed the Company’s Chief Financial Officer. The Agreement is for a term of one year with automatic renewals for successive one year periods unless terminated prior to the beginning of an applicable renewal period.
